Search Results

Expression of estrogen, androgen, and glucocorticoid receptors in recent striae distensae

Authors: Cordeiro, Raquel Cristina Tancsik; Zecchin, Karina Gotardello; de Moraes, Aparecida Machado

Source: International Journal of Dermatology, Volume 49, Number 1, January 2010 , pp. 30-32(3)

Publisher: Blackwell Publishing

Estrogen prevents norepinephrine alpha-2a receptor reversal of stress-induced working memory impairment

Authors: Shansky, Rebecca M.; Bender, Genevieve; Arnsten, A. F. T.

Source: Stress, Volume 12, Number 5, November 2009 , pp. 457-463(7)

Publisher: Informa Healthcare

Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer

Authors: Celebiler Cavusoglu, Aydan; Kilic, Yalın; Saydam, Serdar; Canda, Tulay; Başkan, Zuhal; Sevinc, Ali Ibrahim; Sakizli, Meral

Source: Cancer Science, Volume 100, Number 12, December 2009 , pp. 2341-2345(5)

Publisher: Blackwell Publishing

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

Authors: Simmons, C.; Miller, N.; Geddie, W.; Gianfelice, D.; Oldfield, M.; Dranitsaris, G.; Clemons, M. J.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1499-1504(6)

Publisher: Oxford University Press

Undertreatment of menopausal symptoms and novel options for comprehensive management

Author: Lewis, Vivian

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2689-2698(10)

Publisher: Informa Healthcare

In situ estrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology

Authors: Sasano, Hironobu; Miki, Yasuhiro; Nagasaki, Shuji; Suzuki, Takashi

Source: Pathology International, Volume 59, Number 11, November 2009 , pp. 777-789(13)

Publisher: Blackwell Publishing

What's positive about `triple-negative' breast cancer?

Authors: Hurvitz, Sara A; Finn, Richard S

Source: Future Oncology, Volume 5, Number 7, September 2009 , pp. 1015-1025(11)

Publisher: Future Medicine

Obesity and the Associated Mediators Leptin, Estrogen and IGF-I Enhance the Cell Proliferation and Early Tumorigenesis of Breast Cancer Cells

Authors: Lautenbach, Anne; Budde, Anne; Wrann, Christiane; Teichmann, Birgit; Vieten, Gertrud; Karl, Tim; Nave, Heike

Source: Nutrition and Cancer, Volume 61, Number 4, July 2009 , pp. 484-491(8)

Publisher: Routledge, part of the Taylor & Francis Group

Estrogens Maintain Bone Mass by Regulating Expression of Genes Controlling Function and Life Span in Mature Osteoclasts

Authors: Imai, Yuuki; Youn, Ming-Young; Kondoh, Shino; Nakamura, Takashi; Kouzmenko, Alexander; Matsumoto, Takahiro; Takada, Ichiro; Takaoka, Kunio; Kato, Shigeaki

Source: Annals of the New York Academy of Sciences, Volume 1173, Supplement 1, September 2009 , pp. E31-E39(1)

Publisher: Blackwell Publishing

Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer

Authors: Christgen, Matthias; Christgen, Henriette; Heil, Charlotte; Krech, Till; Länger, Florian; Kreipe, Hans; Lehmann, Ulrich

Source: Cancer Science, Volume 100, Number 9, September 2009 , pp. 1767-1771(5)

Publisher: Blackwell Publishing

Influence of obesity on breast cancer receptor status and prognosis

Authors: Rose, David P; Vona-Davis, Linda

Source: Expert Review of Anticancer Therapy, Volume 9, Number 8, August 2009 , pp. 1091-1101(11)

Publisher: Expert Reviews

Human Exposure to Endocrine Disruptors and Breast Milk

Authors: Stefanidou, M.; Maravelias, C.; Spiliopoulou, C.

Source: Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru, Volume 9, Number 3, September 2009 , pp. 269-276(8)

Publisher: Bentham Science Publishers

Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis

Authors: Boone, J.; van Hillegersberg, R.; Offerhaus, G. J. A.; van Diest, P. J.; Borel Rinkes, I. H. M.; ten Kate, F. J. W.

Source: Diseases of the Esophagus, Volume 22, Number 6, September 2009 , pp. 496-504(9)

Publisher: Blackwell Publishing

Expression of Estrogen Receptor, Progesterone Receptor, and Vascular Endothelial Growth Factor-A in Thyroid Cancer

Authors: Kansakar, Erina; Chang, Yeon-Jeen; Mehrabi, Massoud; Mittal, Vijay

Source: The American Surgeon, Volume 75, Number 9, September 2009 , pp. 785-789(5)

Publisher: Southeastern Surgical Congress

From mechanical loading to collagen synthesis, structural changes and function in human tendon

Authors: Kjær, M.; Langberg, H.; Heinemeier, K.; Bayer, M. L.; Hansen, M.; Holm, L.; Doessing, S.; Kongsgaard, M.; Krogsgaard, M. R.; Magnusson, S. P.

Source: Scandinavian Journal of Medicine & Science in Sports, Volume 19, Number 4, August 2009 , pp. 500-510(11)

Publisher: Blackwell Publishing

Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications

Authors: Cabioglu, N.; Sahin, A. A.; Morandi, P.; Meric-Bernstam, F.; Islam, R.; Lin, H. Y.; Bucana, C. D.; Gonzalez-Angulo, A. M.; Hortobagyi, G. N.; Cristofanilli, M.

Source: Annals of Oncology, Volume 20, Number 6, 13 June 2009 , pp. 1013-1019(7)

Publisher: Oxford University Press

The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes

Authors: Brodowska, Agnieszka; Starczewski, Andrzej; Brodowski, Jacek; Szydłowska, Iwona; Nawrocka-Rutkowska, Jolanta

Source: Gynecological Endocrinology, Volume 25, Number 5, May 2009 , pp. 315-323(9)

Publisher: Informa Healthcare

Effects of estrogen therapy on age-related differences in gray matter concentration

Authors: Robertson, D.; Craig, M.; van Amelsvoort, T.; Daly, E.; Moore, C.; Simmons, A.; Whitehead, M.; Morris, R.; Murphy, D.

Source: Climacteric, Volume 12, Number 4, August 2009 , pp. 301-309(9)

Publisher: Informa Healthcare

How Computational Methods Try to Disclose the Estrogen Receptor Secrecy - Modeling the Flexibility

Authors: Spyrakis, Francesca; Cozzini, Pietro

Source: Current Medicinal Chemistry, Volume 16, Number 23, August 2009 , pp. 2987-3027(41)

Publisher: Bentham Science Publishers

An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

Authors: Henriksen, Katrine; Rasmussen, Birgitte; Lykkesfeldt, Anne; Møller, Susanne; Ejlertsen, Bent; Mouridsen, Henning

Source: Acta Oncologica, Volume 48, Number 4, May 2009 , pp. 522-531(10)

Publisher: Informa Healthcare